Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | Mr. Andrew M. DahlPrincipal Accounting Officer, Senior VP & Corporate Controller | -567.53 | 48.85k | 売り | 86.08 | 2.48k | -18.63% |
| 2026-05-27 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -23.15k | 2.00M | 売り | 86.42 | 133.29k | -14.80% |
| 2026-05-22 | Mr. Daveen ChopraCorp. VP of Transcatheter Mitral & Tricuspid Therapies | -1.50k | 126.91k | 売り | 84.60 | 19.43k | -7.17% |
| 2026-05-18 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -620.00 | 5.25k | Derivative Exercise and Sale | 72.68 - 81.14 | 12.79k | - |
| 2026-05-15 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -17.97k | 1.47M | 売り | 81.82 - 82.07 | 156.44k | -10.30% |
| 2026-05-11 | Mr. Bernard J. ZovighianCEO & Director | -47.21k | 2.09M | Derivative Exercise and Sale | 79.96 | 114.94k | - |
| 2026-05-12 | Mr. Bernard J. ZovighianCEO & Director | -36.35k | 2.83M | Automatic Disposition | 77.92 - 78.40 | 114.94k | -24.03% |
| 2026-05-12 | Mr. Bernard J. ZovighianCEO & Director | -5.63k | 0.00 | Other Disposition | - | 114.94k | -4.67% |
| 2026-05-11 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -7.47k | 597.22k | Derivative Exercise and Sale | 79.96 | 174.40k | - |
| 2026-05-11 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | 5.99k | 0.00 | Derivative Exercise and Retained Stock | - | 174.40k | 3.56% |
| 2026-05-11 | Mr. Daveen ChopraCorp. VP of Transcatheter Mitral & Tricuspid Therapies | -7.54k | 602.74k | Derivative Exercise and Sale | 79.96 | 20.93k | - |
| 2026-05-11 | Mr. Daveen ChopraCorp. VP of Transcatheter Mitral & Tricuspid Therapies | 6.05k | 0.00 | Derivative Exercise and Retained Stock | - | 20.93k | 40.63% |
| 2026-05-11 | Mr. Scott B. Ullemインサイダー | -11.00k | 879.88k | Derivative Exercise and Sale | 79.96 | 294.62k | - |
| 2026-05-11 | Mr. Scott B. Ullemインサイダー | 8.83k | 0.00 | Derivative Exercise and Retained Stock | - | 294.62k | 3.09% |
| 2026-05-07 | Mr. Wayne T. MarkowitzGM & Senior VP of Surgical Structural Heart | -490.00 | 40.67k | Sale to Issuer | 82.76 - 83.20 | 2.25k | -17.88% |
| 2026-05-11 | Mr. Wayne T. MarkowitzGM & Senior VP of Surgical Structural Heart | -593.00 | 47.28k | 売り | 79.73 | 2.25k | -20.85% |
| 2026-05-07 | Mr. Bernard J. ZovighianCEO & Director | -9.55k | 792.27k | Sale to Issuer | 82.76 - 83.20 | 130.28k | -6.83% |
| 2026-05-08 | Mr. Bernard J. ZovighianCEO & Director | -9.71k | 0.00 | Other Disposition | - | 130.28k | -6.94% |
| 2026-05-11 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -362.00 | 28.95k | Sale to Issuer | 79.96 | 12.79k | -2.75% |
| 2026-05-07 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -1.87k | 155.04k | Sale to Issuer | 82.76 - 83.20 | 166.81k | -1.11% |
| 2026-05-07 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -759.00 | 62.95k | Sale to Issuer | 82.76 - 83.20 | 13.15k | -5.46% |
| 2026-05-08 | Mr. Andrew M. DahlPrincipal Accounting Officer, Senior VP & Corporate Controller | -289.00 | 23.92k | Sale to Issuer | 82.76 | 3.05k | -8.67% |
| 2026-05-07 | Mr. Scott B. Ullemインサイダー | -3.03k | 251.70k | Sale to Issuer | 82.76 - 83.20 | 283.43k | -1.06% |
| 2026-05-07 | Mr. Daveen ChopraCorp. VP of Transcatheter Mitral & Tricuspid Therapies | -1.82k | 150.51k | Sale to Issuer | 82.76 - 83.20 | 13.26k | -12.04% |
| 2026-05-08 | Ms. Annette Maria BrulsCorp. VP of EMEA, Canada, & Latin America | -84.00 | 6.95k | Sale to Issuer | 82.76 | 3.38k | -2.43% |
| 2026-05-05 | Mr. Scott B. Ullemインサイダー | 1.87k | 110.75k | Derivative Exercise and Retained Stock | 59.26 | 280.35k | 0.67% |
| 2026-05-05 | Mr. Scott B. Ullemインサイダー | -11.13k | 263.28k | Derivative Exercise and Sale | 59.26 - 82.91 | 280.35k | - |
| 2026-05-03 | Mr. Scott B. Ullemインサイダー | -620.00 | 52.07k | Sale to Issuer | 83.98 | 280.35k | -0.22% |
| 2026-05-03 | Mr. Bernard J. ZovighianCEO & Director | -515.00 | 43.25k | Sale to Issuer | 83.98 | 96.03k | -0.53% |
| 2026-05-05 | Mr. Bernard J. ZovighianCEO & Director | -523.00 | 0.00 | Other Disposition | - | 96.03k | -0.54% |
| 2026-05-01 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -2.04k | 49.40k | Derivative Exercise and Sale | 59.26 - 83.99 | 10.97k | - |
| 2026-05-03 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -252.00 | 21.16k | Sale to Issuer | 83.98 | 10.97k | -2.25% |
| 2026-05-03 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -469.00 | 39.39k | Sale to Issuer | 83.98 | 181.52k | -0.26% |
| 2026-05-03 | Mr. Daveen ChopraCorp. VP of Transcatheter Mitral & Tricuspid Therapies | -282.00 | 23.68k | Sale to Issuer | 83.98 | 11.03k | -2.49% |
| 2026-04-09 | Mr. Scott B. Ullemインサイダー | -13.00k | 270.21k | Derivative Exercise and Sale | 59.26 - 80.50 | 277.85k | - |
| 2026-04-06 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -1.02k | 22.14k | Derivative Exercise and Sale | 59.26 - 80.98 | 11.22k | - |
| 2026-04-02 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -22.68k | 474.11k | Derivative Exercise and Sale | 59.26 - 80.59 | 181.96k | - |
| 2026-03-11 | Mr. Scott B. Ullemインサイダー | -13.00k | 333.56k | Derivative Exercise and Sale | 59.26 - 85.21 | 277.85k | - |
| 2026-03-11 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -1.02k | 26.62k | Derivative Exercise and Sale | 59.26 - 85.38 | 11.22k | - |
| 2026-03-02 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -11.34k | 302.46k | Derivative Exercise and Sale | 59.26 - 85.93 | 181.92k | - |
| 2026-02-25 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -24.00k | 2.01M | 売り | 83.84 | 164.37k | -12.74% |
| 2026-02-22 | Mr. Andrew M. DahlPrincipal Accounting Officer, Senior VP & Corporate Controller | -176.00 | 14.04k | Sale to Issuer | 79.78 | 2.40k | -6.82% |
| 2026-02-22 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -432.00 | 34.46k | Sale to Issuer | 79.78 | 11.22k | -3.71% |
| 2026-02-16 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -456.00 | 34.60k | Sale to Issuer | 75.87 | 11.65k | -3.77% |
| 2026-02-16 | Mr. Scott B. Ullemインサイダー | -199.00 | 15.10k | Sale to Issuer | 75.87 | 277.85k | -0.07% |
| 2026-02-12 | Mr. Bernard J. ZovighianCEO & Director | -25.35k | 217.58k | Derivative Exercise and Sale | 59.26 - 77.13 | 96.15k | - |
| 2026-01-09 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -1.02k | 26.95k | Derivative Exercise and Sale | 59.26 - 85.70 | 12.15k | - |
| 2026-01-06 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -11.34k | 299.46k | Derivative Exercise and Sale | 59.26 - 85.98 | 188.28k | - |
| 2025-12-12 | Ms. Leslie Stone HeiszIndependent Director | -2.62k | 218.12k | 売り | 83.41 | 27.42k | -8.71% |
| 2025-12-12 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -11.39k | 953.75k | 売り | 83.74 - 83.79 | 188.28k | -5.70% |
| 2025-12-12 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -7.10k | 0.00 | Other Disposition | - | 188.28k | -3.63% |
| 2025-12-12 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -1.02k | 25.24k | Derivative Exercise and Sale | 59.26 - 84.03 | 12.11k | - |
| 2025-12-11 | Mr. Daveen ChopraCorp. VP of Transcatheter Mitral & Tricuspid Therapies | -2.00k | 168.75k | 売り | 84.38 | 10.50k | -16.01% |
| 2025-12-08 | Mr. Bernard J. ZovighianCEO & Director | -25.35k | 328.85k | Derivative Exercise and Sale | 59.26 - 85.21 | 93.18k | - |
| 2025-12-10 | Mr. Bernard J. ZovighianCEO & Director | -3.86k | 322.37k | Automatic Disposition | 83.45 | 93.18k | -3.98% |
| 2025-12-10 | Mr. Donald E. BoboCorp. VP of Strategy & Corporate Development | -11.34k | 278.61k | Derivative Exercise and Sale | 59.26 - 83.83 | 206.77k | - |
| 2025-12-09 | Mr. Scott B. Ullemインサイダー | -7.70k | 194.14k | Derivative Exercise and Sale | 59.26 - 84.47 | 277.56k | - |
| 2025-12-08 | Mr. Wayne T. MarkowitzGM & Senior VP of Surgical Structural Heart | -583.00 | 50.14k | 売り | 86.01 | 1.66k | -26.00% |
| 2025-11-10 | Mr. Scott B. Ullemインサイダー | -13.00k | 309.76k | Derivative Exercise and Sale | 59.26 - 83.30 | 277.56k | - |
| 2025-11-10 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -1.02k | 23.75k | Derivative Exercise and Sale | 59.26 - 82.55 | 12.11k | - |
| 2025-09-13 | Mr. Andrew M. DahlPrincipal Accounting Officer, Senior VP & Corporate Controller | -262.00 | 20.32k | Sale to Issuer | 77.57 | 2.40k | -9.83% |
| 2025-09-14 | Mr. Wayne T. MarkowitzGM & Senior VP of Surgical Structural Heart | -650.00 | 50.42k | Sale to Issuer | 77.57 | 2.24k | -22.48% |
| 2025-08-25 | Mr. Daveen ChopraCorp. VP of Transcatheter Mitral & Tricuspid Therapies | -2.50k | 204.87k | 売り | 81.95 | 12.50k | -16.67% |
| 2025-08-18 | Mr. Larry L. Woodインサイダー | -8.95k | 168.33k | Derivative Exercise and Sale | 59.26 - 78.06 | 182.84k | - |
| 2025-07-28 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -4.11k | 326.90k | 売り | 79.46 | 12.11k | -25.36% |
| 2025-07-11 | Ms. Annette Maria BrulsCorp. VP of EMEA, Canada, & Latin America | -109.00 | 8.59k | Sale to Issuer | 78.80 | 3.43k | -3.08% |
| 2025-07-07 | Mr. Daniel J. LippisCorp. VP of JAPAC (Japan, Greater China & Asia Pacific) | -333.00 | 25.57k | Sale to Issuer | 76.79 | 16.22k | -2.01% |
| 2025-06-16 | Mr. Larry L. Woodインサイダー | -8.95k | 142.92k | Derivative Exercise and Sale | 59.26 - 75.23 | 182.84k | - |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
